- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Quantitative proteomic analysis of HER2 protein expression in PDAC tumors ; volume:21 ; number:1 ; day:20 ; month:3 ; year:2024 ; pages:1-9 ; date:12.2024
Clinical proteomics ; 21, Heft 1 (20.3.2024), 1-9, 12.2024
- Creator
-
Randall, Jamie
Hunt, Allison L.
Nutcharoen, Aratara
Johnston, Laura
Chouraichi, Safae
Wang, Hongkun
Winer, Arthur
Wadlow, Raymond
Huynh, Jasmine
Davis, Justin
Corgiat, Brian
Bateman, Nicholas W.
Deeken, John F.
Petricoin, Emanuel F.
Conrads, Thomas P.
Cannon, Timothy L.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12014-024-09476-7
- URN
-
urn:nbn:de:101:1-2405212100268.694037542191
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Randall, Jamie
- Hunt, Allison L.
- Nutcharoen, Aratara
- Johnston, Laura
- Chouraichi, Safae
- Wang, Hongkun
- Winer, Arthur
- Wadlow, Raymond
- Huynh, Jasmine
- Davis, Justin
- Corgiat, Brian
- Bateman, Nicholas W.
- Deeken, John F.
- Petricoin, Emanuel F.
- Conrads, Thomas P.
- Cannon, Timothy L.
- SpringerLink (Online service)
Other Objects (12)
PDAC-Automobilclub
Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis
Quantitative proteomic analysis of aberrant expressed lysine acetylation in gastrointestinal stromal tumors
JNKs are stress-dependent regulators of acinar maintenance and tumor suppressors in PDAC
Therapeutic strategies targeting Kv10.1 in PDAC
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profiling
Tumor small EVs in molecular profiling and as mediators of immune evasion in PDAC
Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset
Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis
PDAC-Automobilclub
Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis
Quantitative proteomic analysis of aberrant expressed lysine acetylation in gastrointestinal stromal tumors
JNKs are stress-dependent regulators of acinar maintenance and tumor suppressors in PDAC
Therapeutic strategies targeting Kv10.1 in PDAC
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profiling
Tumor small EVs in molecular profiling and as mediators of immune evasion in PDAC
Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset
Prognostic role of HER2 amplification based on fluorescence in situ hybridization (FISH) in pancreatic ductal adenocarcinoma (PDAC): a meta-analysis
PDAC-Automobilclub
Reprogramming tumor-associated macrophages with lipid nanosystems reduces PDAC tumor burden and liver metastasis
Quantitative proteomic analysis of aberrant expressed lysine acetylation in gastrointestinal stromal tumors
JNKs are stress-dependent regulators of acinar maintenance and tumor suppressors in PDAC
Therapeutic strategies targeting Kv10.1 in PDAC
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
PDAC: Profitieren Hochrisikoindividuen von einer Langzeitüberwachung?
Comparison of tumors with HER2 overexpression versus HER2 amplification in HER2-positive breast cancer patients
The tumor immune microenvironment of primary and metastatic HER2− positive breast cancers utilizing gene expression and spatial proteomic profiling
Tumor small EVs in molecular profiling and as mediators of immune evasion in PDAC
Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset